National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

Read this book online, free! Click here to proceed to linked table of contents

New Vaccine Development:

Establishing Priorities: Volume I, Diseases of Importance in the United States

Book Cover

Status: Not for Sale

Size: 472 pages, 8 1/2 x 11

Publication Year:1985

E-mail this page
PDF     About PDF

Authors:
Committee on Issues and Priorities for New Vaccine Development, Division of Health Promotion and Disease Prevention
Authoring Organizations


Paste into your Web page:

Preview
Free Resources
Read

Full Text
Jump to this book's table of contents to begin reading online for free.

Research Tools
Download Free

PDF Summary
Download the summary in PDF.

Rights & Permissions

Reprint Permission
Request permission to license or reprint the book's content through Copyright Clearance Center's Rightslink.

Request Permission to Distribute a PDF

Request Translation Rights

Questions About Rights and Permissions?

Table of Contents
Select a link below to start reading online free!
Front Matter i-xiv  
1. Summary 1-16 (skim)
2. Priority Setting for Health Related Investments: A Review of Methods 17-27 (skim)
3. Overview of the Analytic Approach 28-38 (skim)
4. Comparison of Disease Burdens and Costs 39-58 (skim)
5. Predictions on Vaccine Development 59-66 (skim)
6. Assessing the Likely Utilization of New Vaccines 67-91 (skim)
7. Calculation and Comparison of the Health Benefits and Costs Associated with Candidate Vaccines 92-120 (skim)
8. Additional Issues in the Selection of Priorities for Accelerated Vaccine Development 121-126 (skim)
9. Findings, Conclusions, and Recommendations 127-148 (skim)
Appendix A: Some Examples of the Application of Project Selection Method 149-152 (skim)
Appendix B: Pathogenic Agents for Which Accelerated Vaccine Development Does Not Appear Appropriate 153-170 (skim)
Appendix C: Prospects for Immunizing Against Bordetella pertussis 171-182 (skim)
Appendix D: Prospects for Immunizing Against Coccidioidomycosis 183-197 (skim)
Appendix E: Prospects for Immunizing Against Cytomegalovirus 198-234 (skim)
Appendix F: Prospects for Immunizing Against Hemophilus influenzae type b 235-251 (skim)
Appendix G: Prospects for Immunizing Against Hepatitis A Virus 252-260 (skim)
Appendix H: Prospects for Immunizing Against Hepatitis B Virus 261-279 (skim)
Appendix I: Prospects for Immunizing Against Herpes Simplex Viruses 1 and 2 280-312 (skim)
Appendix J: Prospects for Immunizing Against Herpesvirus varicellae 313-341 (skim)
Appendix K: Prospects for Immunizing Against Influenza Viruses A and B 342-364 (skim)
Appendix L: Prospects for Immunizing Against Neisseria gonorrhoeae 365-384 (skim)
Appendix M: Prospects for Immunizing Against Parainfluenza Viruses 385-396 (skim)
Appendix N: Prospects for Immunizing Against Respiratory Syncytial Virus 397-409 (skim)
Appendix O: Prospects for Immunizing Against Rotavirus 410-423 (skim)
Appendix P: Prospects for Immunizing Against Streptococcus group B 424-439 (skim)
Appendix Q: Questionnaire for Assessing Morbidity-Mortality Trade-Offs 440-443 (skim)
Appendix R: Technical Notes 444-444 (skim)
Appendix S: Biographical Notes on Committee Members 445-449 (skim)
Appendix T: Additional Sources of Advice to the Committee 450-452 (skim)
Index 453-458 (skim)

Search This Book

»Find more like this book

SIGN UP FOR...

New Title Emails
Read about the newest releases and receive special offers.